<unk>  is resistant to amphotericin B and nearly all other antifungal drugs. Consequently, there is currently no consistently effective antifungal therapy for this agent. Miconazole has shown the best in vivo activity; however, itraconazole, fluconazole, ketoconazole and voriconazole have also been used in treatment, albeit with less success. In an in vitro environment, terbinafine has been found to work in synergy with azoles against P.<unk> . Echinocandins, such as caspofungin and sordarins, have shown promise in in vitro assays. CMT-3, a chemically modified tetracycline, has also shown to be active in vitro against P.<unk> .
Pseudallescheria boydii
Helicobacter bizzozeronii
Bacteroides caccae
Prevotella bivia
Helicobacter heilmannii s.s
Pasteurella
Madurella grisea
Hortaea werneckii